Springer Nature leases 1.1 lakh sq ft of office space in Pune for 10 years

Valued at about $17 million over the tenure of the lease, it is spread across two floors of the 7,00,000 sq ft building; the company has the option to take on an additional 56,000 sq ft.

Moneycontrol News

April 25, 2023 / 13:53 IST

The office space, located in Kharadi's Gera Commerzone, will span two floors of the 7,00,000 sq ft building, and Springer Nature has the option to take up an additional 56,000 sq ft for further expansion.

Global scientific research publishing company Springer Nature Group has leased an office space spread across 1.1 lakh square feet (sq ft) valued at approximately $17 million, for 10 years in Pune.

The transaction was initiated post-COVID when Springer Nature recognised the need for a futuristic workspace that prioritises the well-being of its employees and facilitates a safe return to office.

JLL acted as the exclusive partner in this transaction.

“Kharadi is now a preferred location for corporate occupiers owing to the excellent social infrastructure, top-notch schools, hospitals and residential communities, coupled with excellent connectivity and proximity to the airport. The tenant profile is remarkable, featuring a diverse range of large multinational corporations from the BFSI, IT/ITeS, e-commerce and engineering sectors, among others," said Sanjay Bajaj, managing director, Pune, JLL.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show